Cleared Traditional

K240666 - Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface (BB811) (FDA 510(k) Clearance)

Also includes:
Affinity Fusion Oxygenator with Integrated Arterial Filter and Cardiotomy/Venous Reservoir with Balance Biosurface (BB841) Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface NON STERILE (BB811-NS)
Jul 2024
Decision
124d
Days
Class 2
Risk

K240666 is an FDA 510(k) clearance for the Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface (BB811). This device is classified as a Oxygenator, Cardiopulmonary Bypass (Class II - Special Controls, product code DTZ).

Submitted by Medtronic Perfusion Systems (Minneapolis, US). The FDA issued a Cleared decision on July 10, 2024, 124 days after receiving the submission on March 8, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4350.

Submission Details

510(k) Number K240666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2024
Decision Date July 10, 2024
Days to Decision 124 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DTZ — Oxygenator, Cardiopulmonary Bypass
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4350